Novo Nordisk
Novo Nordisk is a multinational pharmaceutical company established in Denmark. Novo Nordisk is a worldwide healthcare firm with over 90 years of diabetes care innovation and leadership. Novo Nordisk, headquartered in Denmark, employs roughly 41,600 people in 79 countries and sells its medicines in over 170 countries as of 2019.
Their mission is to inspire change in the fight against diabetes and other significant chronic diseases including obesity, as well as uncommon blood and endocrine abnormalities. They do so through breaking new ground in science, increasing access to their medications, and trying to prevent and eventually cure disease.
Novo Nordisk employs around 47,000 employees in 80 countries and sells its products in over 170. Annual Revenues are 122,021 million DKK and Net Income is 38,951 million DKK as of December 2019.
Founded: December 21, 1923
Headquarters: Bagsværd, DenmarkMarket Cap: 229.040 Billion USD
Website: https://www.novonordisk-us.com/